Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Egetis Therapeutics - Filing #5995613

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
NOT 13
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
4,122,000,000 SEK
4,143,000,000 SEK
Current assets
3,801,000,000 SEK
3,459,000,000 SEK
Non-current liabilities
952,000,000 SEK
1,108,000,000 SEK
Current liabilities
2,042,000,000 SEK
1,039,000,000 SEK
Profit (loss)
3,436,000,000 SEK
3,269,000,000 SEK
Other comprehensive income
1,000,000 SEK
1,000,000 SEK
Comprehensive income
3,435,000,000 SEK
- SEK
- SEK
- SEK
3,435,000,000 SEK
- SEK
- SEK
3,270,000,000 SEK
3,270,000,000 SEK
- SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.